February 14, 2017 / 9:56 PM / in 9 months

BRIEF-Pharmacan Capital announces $15 million bought deal

Feb 14 (Reuters) - Pharmacan Capital Corp:

* Pharmacan Capital announces $15 million bought deal

* Has entered into a letter of engagement with eight capital on behalf of a syndicate of underwriters

* Pharmacan Capital Corp - underwriters have agreed to purchase 6.7 million common shares of company on a “bought deal” basis at a price per share of $2.25

* Closing date of offering is scheduled to be on or about March 9, 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below